Josh Wilkerson switched to a cheaper insulin when the price of his life-saving medication went up, a decision that ended up being fatal.
Who better to appoint as the new U.S. Secretary of Health and Human Services than an actual Big Pharma executive like Alex Azar?
How a billionaire pharmaceutical family is making a fortune off the opioid crisis — and yet their name is plastered on museums and universities all over the world.
2015, the year of prescription drug outrage.
Macroeconomic pressures have hit the R&D returns of life sciences firms.